StockData
Pure Bioscience, Inc. logo

Pure Bioscience, Inc. (PURE) stock

PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 1/30
$0.07−0.01 (-12.10%)

Close on Oct 19, 2026Market cap $8.67MP/E –Yield –

Pure Bioscience revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Pure Bioscience's revenue for the twelve months ending Jul 31, 2026 was $2.32M, up 5.3% year over year. For fiscal 2026 it was $2.32M, up 5.3% from the year before. Over ten years it grew 6.0% a year on average. The highest annual figure on record is $6.92M in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2026Jul 31, 2026$2.32M+5.3%
FY2025Jul 31, 2025$2.20M+12.4%
FY2024Jul 31, 2024$1.96M+4.5%
FY2023Jul 31, 2023$1.87M+3.2%
FY2022Jul 31, 2022$1.81M-51.0%
FY2021Jul 31, 2021$3.70M-46.5%
FY2020Jul 31, 2020$6.92M+262.3%
FY2019Jul 31, 2019$1.91M+7.6%
FY2018Jul 31, 2018$1.77M-3.1%
FY2017Jul 31, 2017$1.83M+42.0%
FY2016Jul 31, 2016$1.29M+76.8%
FY2015Jul 31, 2015$729.00K+32.5%
FY2014Jul 31, 2014$550.00K-32.9%
FY2013Jul 31, 2013$820.00K+1.0%
FY2012Jul 31, 2012$812.00K+75.0%
FY2011Jul 31, 2011$464.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jul 31, 2026$659.00K-13.6%
Q3 FY2026CQ1 2026Apr 30, 2026$506.00K+3.5%
Q2 FY2026CQ4 2025Jan 31, 2026$443.00K+13.3%
Q1 FY2026CQ3 2025Oct 31, 2025$707.00K+27.4%
Q4 FY2025CQ2 2025Jul 31, 2025$763.00K+61.7%
Q3 FY2025CQ1 2025Apr 30, 2025$489.00K+11.1%
Q2 FY2025CQ4 2024Jan 31, 2025$391.00K+20.3%
Q1 FY2025CQ3 2024Oct 31, 2024$555.00K-22.7%
Q4 FY2024CQ2 2024Jul 31, 2024$472.00K-21.6%
Q3 FY2024CQ1 2024Apr 30, 2024$440.00K+8.4%
Q2 FY2024CQ4 2023Jan 31, 2024$325.00K-17.9%
Q1 FY2024CQ3 2023Oct 31, 2023$718.00K+53.7%
Q4 FY2023CQ2 2023Jul 31, 2023$602.00K+49.0%
Q3 FY2023CQ1 2023Apr 30, 2023$406.00K-18.3%
Q2 FY2023CQ4 2022Jan 31, 2023$396.00K-4.6%
Q1 FY2023CQ3 2022Oct 31, 2022$467.00K-6.0%
Q4 FY2022CQ2 2022Jul 31, 2022$404.00K-52.9%
Q3 FY2022CQ1 2022Apr 30, 2022$497.00K-10.6%
Q2 FY2022CQ4 2021Jan 31, 2022$415.00K-52.2%
Q1 FY2022CQ3 2021Oct 31, 2021$497.00K-64.9%
Q4 FY2021CQ2 2021Jul 31, 2021$857.00K-78.3%
Q3 FY2021CQ1 2021Apr 30, 2021$556.00K-75.0%
Q2 FY2021CQ4 2020Jan 31, 2021$868.00K+148.7%
Q1 FY2021CQ3 2020Oct 31, 2020$1.42M+256.0%
Q4 FY2020CQ2 2020Jul 31, 2020$3.95M+544.2%
Q3 FY2020CQ1 2020Apr 30, 2020$2.22M+611.9%
Q2 FY2020CQ4 2019Jan 31, 2020$349.00K-11.4%
Q1 FY2020CQ3 2019Oct 31, 2019$398.00K-32.5%
Q4 FY2019CQ2 2019Jul 31, 2019$613.00K+20.4%
Q3 FY2019CQ1 2019Apr 30, 2019$312.00K-20.0%
Q2 FY2019CQ4 2018Jan 31, 2019$394.00K-4.1%
Q1 FY2019CQ3 2018Oct 31, 2018$590.00K+27.2%
Q4 FY2018CQ2 2018Jul 31, 2018$509.00K-1.2%
Q3 FY2018CQ1 2018Apr 30, 2018$390.00K+15.4%
Q2 FY2018CQ4 2017Jan 31, 2018$411.00K-8.1%
Q1 FY2018CQ3 2017Oct 31, 2017$464.00K-12.6%
Q4 FY2017CQ2 2017Jul 31, 2017$515.00K–
Q3 FY2017CQ1 2017Apr 30, 2017$338.00K–
Q2 FY2017CQ4 2016Jan 31, 2017$447.00K–
Q1 FY2017CQ3 2016Oct 31, 2016$531.00K–

More Pure Bioscience figures

See a number that looks wrong?